-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
All investors
114 institutional investors
Content Filter
-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
-
GL Ventures
- Investments: 425
- Funds: 38
- Zhuhai, Guangdong Province
-
Energy storage
-
Electric vehicles
-
New materials
Hillhouse Investment is a venture capital brand under the Hillhouse Group that focuses on investing in early-stage innovative enterprises. Since our establishment, Hillhouse Group has always focused on early-stage technological innovation investment in projects including Horizon Robotics, BeiGene, ZOOM, Blue Moon, and Ijovo.
-
Gaorong Capital
- Investments: 465
- Funds: 12
- Beijing
-
Lithium batteries
-
Other renewable energy (nuclear, geothermal, etc.)
Founded in 2014, Gaorong Capital is one of the most active venture capital institutions in China. Gaorong Capital profoundly cultivates innovative and entrepreneurial fields such as new consumption, new technology, medical care and health, and invests in innovative and growing enterprises. Up to now, Gaorong has invested in more than 200 enterprises. In the fields of new consumption, we continue to look for opportunities in the domains of "new e-commerce", "new retail", "new brand", "new entertainment" and "new infrastructure"; in the field of new technologies, Gaorong is deeply involved in new technology fields such as artificial intelligence, intelligent hardware, robots, chips, corporate services and industrial upgrading; in the field of medical and health care, we invest in outstanding enterprises in digital health, medical services, new drug research and development, medical devices and testing.
-
GGV Capital
- Investments: 763
- Funds: 15
- Shanghai
-
Electric vehicles
-
Grid/power transmission
-
Green transportation
GGV Capital is a venture capital company focusing on global early and mid-stage enterprises. We manage a total of 17 funds with assets of US$9.2 billion, with offices in Silicon Valley, San Francisco, Shanghai, Beijing, and Singapore. GGV Capital focuses on startups in the fields of consumption and new retailing, Internet services, cutting-edge technology, enterprise services, and cloud. We have invested in more than 400 companies, including Alibaba, Didi, Qunar, Airbnb, Full Truck Alliance, and Toutiao. By the end of 2020, GGV had 281 companies under management. We pay long-term attention to the global market and dive into localization and integration. We have accumulated unique resources and will fully support entrepreneurs to continue exploring and innovating.
-
Qiming VC
- Investments: 671
- Funds: 26
- Shanghai
-
Lithium batteries
-
Electric vehicles
-
Low-carbon consumer goods
-
Digital technology for carbon accounting and consulting
-
Circular economy
Qiming Venture Partners is a top-tier VC firm with outstanding reputation. With our exceptional investment performances, we have been widely recognized by investors from around the world. We have a reputation for being entrepreneur friendly.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages. Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi , Meituan, Bilibili, Zhihu, Roborock, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, New Horizon Health, Venus MedTech, Sanyou Medical, AmoyDx, Berry Genomics, SinocellTech, Yuanxin Technology, dMed-Clinipace, Belief BioMed, WeRide, Biren Technology and UBTech among many others.
-
Oceanpine Capital
- Investments: 83
- Funds: 17
- Hong Kong
-
Energy storage
-
Lithium batteries
Oceanpine Capital is an institutional growth equity investment company that invests in innovative and disruptive growth companies in TMT and health care, which are the driving forces of the newly regulated future economy. Oceanpine Capital believes in long-term value investment and provides strategic financing resources and operational support for invested enterprises. The trading types of Oceanpine Capital are oriented to early growth and growth capital. Since its inception, Oceanpine Capital has invested in more than 70 companies in China and the U.S., mostly in the TMT and healthcare sectors, with more than a dozen of them making successful initial public offerings. The total investment amount has exceeded US $3 billion. Invested enterprises include Hina Battery, Svolt, BEST Semiconductor, Shansong, Mingmed, Giant Biogene, etc.